Triton Financial Group Inc bought a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 13,829 shares of the company’s stock, valued at approximately $1,777,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Frazier Financial Advisors LLC bought a new stake in Merck KGaA in the second quarter worth $25,000. Rakuten Securities Inc. bought a new position in Merck KGaA during the second quarter valued at $27,000. Delos Wealth Advisors LLC bought a new position in Merck KGaA during the second quarter valued at $33,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at $33,000. Finally, Burk Holdings LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at $39,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Merck KGaA stock opened at $158.15 on Friday. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average price of $163.21 and a 200-day moving average price of $148.95. The firm has a market capitalization of $20.44 billion, a PE ratio of 24.14 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
